Chemical formula: C₁₈H₁₆Cl₂N₂O₂ Molecular mass: 362.059 g/mol PubChem compound: 4177
Mexazolam is a benzodiazepine indicated for the management of anxiety disorder associated or not to psychoneurotic conditions. The exact sites and mode of action have not been fully elucidated, but it appears to be mediated through the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), by the stimulation of specific receptors. Both GABA and chloride may enhance the binding to those receptors.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N05BA25 | N Nervous system → N05 Psycholeptics → N05B Anxiolytics → N05BA Benzodiazepine derivatives | |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| SEDOXIL Tablet | Web Search | MPI, EU: SmPC |
Mexazolam is an active ingredient of these brands:
Japan (JP)Malta (MT)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
